ALNY vs HROW · P/E 76, rev $1.29B vs rev $114.9M
Alnylam Pharmaceuticals Inc (ALNY) versus Harrow Health Inc (HROW) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Harrow Health Inc (HROW) is a drug manufacturers - specialty & generic company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported HROW revenue for 2026-06-30 was $114.9M. Net income was -$44.9M. HROW currently screens at market cap $1.28B.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. HROW currently screens at market cap $1.28B.
Not investment advice. Open the ALNY and HROW stock pages for the full models.
Not investment advice.